Table 4: AUC24 and Cmax Correlation with AKI
AUC24 < 80 (n=31) AUC24 < 80 (n=31)
Developed AKI, n (%) 14 (45.2)
Did NOT Develop AKI, n (%) 17 (54.8)
AUC24 ≥ 80 (n=120) AUC24 ≥ 80 (n=120)
Developed AKI, n (%) 34 (28.3)
Did NOT Develop AKI, n (%) 86 (71.7)
Pearson Chi-Square 2-sided significance: p=0.147 Pearson Chi-Square 2-sided significance: p=0.147
Cmax < 8-fold the highest PsA MIC (n=77) Cmax < 8-fold the highest PsA MIC (n=77)
Developed AKI, n (%) 28 (36.4)
Did NOT Develop AKI, n (%) 49 (63.6)
Cmax ≥ 8-fold the highest PsA MIC (n=74) Cmax ≥ 8-fold the highest PsA MIC (n=74)
Developed AKI, n (%) 20 (27)
Did NOT Develop AKI, n (%) 54 (73)
Pearson Chi-Square 2-sided significance: p=0.218 Pearson Chi-Square 2-sided significance: p=0.218